It’s a big day for strengthening Ontario’s clinical trials environment! AstraZeneca is investing $820M, creating more than 700 highly-skilled jobs and expanding their R&D hub in Ontario.
“AstraZeneca’s continued investment in Ontario’s life sciences sector has played an enormous role in establishing this province as a leader in health research and clinical trials, bringing highly skilled jobs and innovative therapies to Ontarians,” said Susan Marlin President & CEO of Clinical Trials Ontario, who was at today’s announcement. “This is a testament to the power of collaboration. When leaders come together from government, industry and the life sciences community, we can build an engine that will drive economic growth and fuel the future of medicine.”